Literature DB >> 7917867

Hyperphosphatemia in tumor lysis syndrome: the role of hemodialysis and continuous veno-venous hemofiltration.

A Sakarcan1, R Quigley.   

Abstract

We report a 4-year-old boy who developed tumor lysis syndrome complicated by severe hyperphosphatemia and acute renal failure, following chemotherapy for T-cell acute lymphoblastic leukemia. Despite successful treatment of hyperphosphatemia with hemodialysis, there was an immediate rebound in the high serum phosphorus level. The patient underwent a second treatment with hemodialysis which was then followed by continuous veno-venous hemofiltration (CVVH). CVVH maintained his serum phosphorus at a stable level until his renal function improved. CVVH can be used in conjunction with hemodialysis to successfully treat the hyperphosphatemia associated with tumor lysis syndrome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7917867     DOI: 10.1007/bf00866363

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  6 in total

1.  The nucleic acids and other phosphorus compounds of human leukemic leukocytes: relation to cell maturity.

Authors:  M L DUERST; M E JUMP; E E OSGOOD; D A RIGAS
Journal:  J Lab Clin Med       Date:  1956-09

2.  Hyperphosphatemia, hypocalcemia, and transient renal failure. Results of cytotoxic treatment of acute lymphoblastic leukemia.

Authors:  D S Ettinger; W G Harker; H W Gerry; R C Sanders; R Saral
Journal:  JAMA       Date:  1978-06-09       Impact factor: 56.272

3.  Hyperphosphatemia, hyperphosphaturia and hypocalcemia in acute lymphoblastic leukemia.

Authors:  J Zusman; D M Brown; M E Nesbit
Journal:  N Engl J Med       Date:  1973-12-20       Impact factor: 91.245

4.  Transient acute renal failure due to tumor-lysis-induced severe phosphate load in a patient with Burkitt's lymphoma.

Authors:  J Monballyu; P Zachee; R Verberckmoes; M A Boogaerts
Journal:  Clin Nephrol       Date:  1984-07       Impact factor: 0.975

5.  Acute tumor lysis syndrome. A review of 37 patients with Burkitt's lymphoma.

Authors:  L F Cohen; J E Balow; I T Magrath; D G Poplack; J L Ziegler
Journal:  Am J Med       Date:  1980-04       Impact factor: 4.965

6.  Postchemotherapy purine excretion in lymphoma patients receiving allopurinol.

Authors:  K R Hande; C V Hixson; B A Chabner
Journal:  Cancer Res       Date:  1981-06       Impact factor: 12.701

  6 in total
  4 in total

Review 1.  Kidney diseases associated with haematological cancers.

Authors:  Anirban Ganguli; Deirdre Sawinski; Jeffrey S Berns
Journal:  Nat Rev Nephrol       Date:  2015-06-02       Impact factor: 28.314

Review 2.  Tumor lysis syndrome: new challenges and recent advances.

Authors:  F Perry Wilson; Jeffrey S Berns
Journal:  Adv Chronic Kidney Dis       Date:  2014-01       Impact factor: 3.620

Review 3.  Tumor lysis syndrome: pathogenesis and management.

Authors:  D P Jones; H Mahmoud; R W Chesney
Journal:  Pediatr Nephrol       Date:  1995-04       Impact factor: 3.714

Review 4.  Tumor lysis syndrome in childhood malignancies.

Authors:  Wing Lum Cheung; Kam Lun Hon; Cheuk Man Fung; Alexander Kc Leung
Journal:  Drugs Context       Date:  2020-02-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.